ELF2
ETS-related transcription factor Elf-2
Also known as: ELF2_HUMAN, EU32, NERF, NERF-1A, NERF-1B, NERF-2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15723
- Gene
- ELF2
- Ensembl
- ENSG00000109381
- Chromosome
- 4
- Canonical length
- 593 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nuclear bodies
OverviewNCBI Gene
Enables DNA-binding transcription factor activity, RNA polymerase II-specific and sequence-specific double-stranded DNA binding activity. Involved in negative regulation of DNA-templated transcription; positive regulation of DNA-templated transcription; and regulation of transcription by RNA polymerase II. Located in cytosol and nuclear body. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
593 residues, UniProt reviewed canonical sequence.
>Q15723|ELF2
1 MTSAVVDSGG TILELSSNGV ENQEESEKVS EYPAVIVEPV PSARLEQGYA AQVLVYDDET
61 YMMQDVAEEQ EVETENVETV EASVHSSNAH CTDKTIEAAE ALLHMESPTC LRDSRSPVEV
121 FVPPCVSTPE FIHAAMRPDV ITETVVEVST EESEPMDTSP IPTSPDSHEP MKKKKVGRKP
181 KTQQSPISNG SPELGIKKKP REGKGNTTYL WEFLLDLLQD KNTCPRYIKW TQREKGIFKL
241 VDSKAVSKLW GKHKNKPDMN YETMGRALRY YYQRGILAKV EGQRLVYQFK DMPKNIVVID
301 DDKSETCNED LAGTTDEKSL ERVSLSAESL LKAASSVRSG KNSSPINCSR AEKGVARVVN
361 ITSPGHDASS RSPTTTASVS ATAAPRTVRV AMQVPVVMTS LGQKISTVAV QSVNAGAPLI
421 TSTSPTTATS PKVVIQTIPT VMPASTENGD KITMQPAKII TIPATQLAQC QLQTKSNLTG
481 SGSINIVGTP LAVRALTPVS IAHGTPVMRL SMPTQQASGQ TPPRVISAVI KGPEVKSEAV
541 AKKQEHDVKT LQLVEEKPAD GNKTVTHVVV VSAPSAIALP VTMKTEGLVT CEKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ELF2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.63
- Highest tissue expression
- 45 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 45 nTPM
- testis: 35 nTPM
- skeletal muscle: 34 nTPM
- tongue: 31 nTPM
- thymus: 31 nTPM
- retina: 28 nTPM
Single-cell type
- neutrophils: 4,634 nCPM
- myonuclei: 868 nCPM
- neutrophil progenitors: 829 nCPM
- monocytes: 660 nCPM
- retinal ganglion cells: 537 nCPM
- salivary basal cells: 526 nCPM
Immune cell
- naive B-cell: 20 nTPM
- plasmacytoid DC: 18 nTPM
- memory B-cell: 18 nTPM
- naive CD4 T-cell: 15 nTPM
- eosinophil: 14 nTPM
- naive CD8 T-cell: 14 nTPM
Brain region
- white matter: 40 nTPM
- cerebellum: 39 nTPM
- basal ganglia: 35 nTPM
- medulla oblongata: 33 nTPM
- pons: 33 nTPM
- hypothalamus: 32 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ELF2.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 84 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.26
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 1.59
- DepMap mean gene effect
- -0.21
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- negative regulation of DNA-templated transcription
- positive regulation of DNA-templated transcription
- regulation of transcription by RNA polymerase II
Molecular functions
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ELF2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ELF2 as an antibody target. Whether an autoantibody or antibody against ELF2 could matter depends on whether native ELF2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ELF2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ELF2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...